En Es
Categories

DIASORIN

DIASORIN

DiaSorin develops, produces and commercializes diagnostic tests for a wide range of clinical areas. The company’s tests are designed for hospital and private testing laboratories in the markets of immunodiagnostics and molecular diagnostics.
Products Covid-19NewsSummary
Close

Covid-19 DIASORIN

Clinical Laboratory

SARS-CoV-2 Ag Assay
LIAISON SARS-CoV-2 Ag

The LIAISON SARS-CoV-2 Ag assay is a chemiluminescence sandwich-immunoassay (CLIA) based technology for the quantitative determination of Nucleocapsid antigen protein from SARS-CoV-2 samples - in nasal swab (NS), nasopharyngeal swab (NPS) eluted in UTM/VTM directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 10 days of the onset of symptoms. The assay is a unique quantitative solution to detect suspected COVID-19 patients, do contact tracing and rapidly implement isolation procedures for those patients who have been infected and might be able to spread SARS-CoV-2.
More details

SARS-CoV-2 IgM Assay
LIAISON SARS-CoV-2 IgM

The LIAISON SARS-CoV-2 IgM is a fully automated assay to be run on LIAISON X for detecting IgM antibody to the SARS-CoV-2 virus that causes COVID-19. The assay offers high sensitivity and specificity to ensure accurate results along the infection window.
More details

SARS-CoV-2 TrimericS IgG Assay
LIAISON SARS-CoV-2 TrimericS IgG Assay

The LIAISON SARS-CoV-2 TrimericS IgG Assay is a new generation of chemiluminescence immunoassay (CLIA), for the quantitative determination of anti-trimeric spike protein specific IgG antibodies to SARS-CoV-2 in human serum or plasma samples. The assay is intended as an aid in the diagnosis of CoVID-19 and to support the study of the immune status of infected patients by providing an indication of the presence of neutralizing IgG antibodies against SARS-CoV-2.
More details

SARS-CoV-2 S1/S2 IgG Assay
LIAISON SARS-CoV-2 S1/S2 IgG

The LIAISON SARS-CoV-2 S1/S2 IgG is a quantitative assay for the detection of IgG antibodies against S1/S2 antigens of SARS-CoV-2. The fully automated solution with a throughput of up to 170 results/hour on LIAISON XL has high sensitivity and specificity to ensure accurate results. The quantitative assay with correlation to neutralizing antibodies can be used as an upstream pre-screening tool.
More details
Close

News of DIASORIN

DiaSorin to Acquire Siemens' ELISA Immunodiagnostics Business

01 Aug 2017
DiaSorin to Acquire Siemens' ELISA Immunodiagnostics Business
DiaSorin S.p.A. has entered into an agreement to acquire Siemens Healthineers’ micro-titre-based ELISA immunodiagnostic business portfolio and related tangible and intangible assets, including customer sales and distribution contracts, installed base of instruments and relevant intellectual property.
Read More
Close

About DIASORIN

DiaSorin develops, produces and commercializes diagnostic tests for a wide range of clinical areas. The company’s tests are designed for hospital and private testing laboratories in the markets of immunodiagnostics and molecular diagnostics.

Recently updated

SARS-CoV-2 S1/S2 IgG Assay
LIAISON SARS-CoV-2 S1/S2 IgG

The LIAISON SARS-CoV-2 S1/S2 IgG is a quantitative assay for the detection of IgG antibodies against S1/S2 antigens of SARS-CoV-2. The fully automated solution with a throughput of up to 170 results/hour on LIAISON XL has high sensitivity and specificity to ensure accurate results. The quantitative assay with correlation to neutralizing antibodies can be used as an upstream pre-screening tool.
More details

SARS-CoV-2 TrimericS IgG Assay
LIAISON SARS-CoV-2 TrimericS IgG Assay

The LIAISON SARS-CoV-2 TrimericS IgG Assay is a new generation of chemiluminescence immunoassay (CLIA), for the quantitative determination of anti-trimeric spike protein specific IgG antibodies to SARS-CoV-2 in human serum or plasma samples. The assay is intended as an aid in the diagnosis of CoVID-19 and to support the study of the immune status of infected patients by providing an indication of the presence of neutralizing IgG antibodies against SARS-CoV-2.
More details

SARS-CoV-2 IgM Assay
LIAISON SARS-CoV-2 IgM

The LIAISON SARS-CoV-2 IgM is a fully automated assay to be run on LIAISON X for detecting IgM antibody to the SARS-CoV-2 virus that causes COVID-19. The assay offers high sensitivity and specificity to ensure accurate results along the infection window.
More details

Clinical Laboratory

SARS-CoV-2 S1/S2 IgG Assay
LIAISON SARS-CoV-2 S1/S2 IgG

The LIAISON SARS-CoV-2 S1/S2 IgG is a quantitative assay for the detection of IgG antibodies against S1/S2 antigens of SARS-CoV-2. The fully automated solution with a throughput of up to 170 results/hour on LIAISON XL has high sensitivity and specificity to ensure accurate results. The quantitative assay with correlation to neutralizing antibodies can be used as an upstream pre-screening tool.
More details

SARS-CoV-2 TrimericS IgG Assay
LIAISON SARS-CoV-2 TrimericS IgG Assay

The LIAISON SARS-CoV-2 TrimericS IgG Assay is a new generation of chemiluminescence immunoassay (CLIA), for the quantitative determination of anti-trimeric spike protein specific IgG antibodies to SARS-CoV-2 in human serum or plasma samples. The assay is intended as an aid in the diagnosis of CoVID-19 and to support the study of the immune status of infected patients by providing an indication of the presence of neutralizing IgG antibodies against SARS-CoV-2.
More details

SARS-CoV-2 IgM Assay
LIAISON SARS-CoV-2 IgM

The LIAISON SARS-CoV-2 IgM is a fully automated assay to be run on LIAISON X for detecting IgM antibody to the SARS-CoV-2 virus that causes COVID-19. The assay offers high sensitivity and specificity to ensure accurate results along the infection window.
More details

SARS-CoV-2 Ag Assay
LIAISON SARS-CoV-2 Ag

The LIAISON SARS-CoV-2 Ag assay is a chemiluminescence sandwich-immunoassay (CLIA) based technology for the quantitative determination of Nucleocapsid antigen protein from SARS-CoV-2 samples - in nasal swab (NS), nasopharyngeal swab (NPS) eluted in UTM/VTM directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 10 days of the onset of symptoms. The assay is a unique quantitative solution to detect suspected COVID-19 patients, do contact tracing and rapidly implement isolation procedures for those patients who have been infected and might be able to spread SARS-CoV-2.
More details

Hepatitis D Assay
LIAISON XL Anti-HDV

The LIAISON XL Anti-HDV assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative detection of total antibodies to hepatitis D virus in human serum and plasma samples. The assay results, in conjunction with other laboratory results and clinical information, are intended to be used as an aid in the diagnosis of HDV infection and as a screening test for organ and tissue donors.
More details

Calprotectin Test
LIAISON Calprotectin Test

The LIAISON Calprotectin test provides fast, reliable and automated detection of calprotectin in feces that is a marker used to help differentiate IBS (Irritable Bowel Syndrome) from IBD (Inflammatory Bowel Disease) and assess disease activity in IBD. Calprotectin is a heterocomplex composed of the calcium and zinc binding proteins S100A8 and S100A9, is resistant to enzymatic degradation, and can be easily measured in feces, making it ideal for direct detection by immunochemistry methods.
More details

Tuberclosis Assay
LIAISON QuantiFERON-TB Gold Plus

The LIAISON QuantiFERON-TB Gold Plus is a fully automated CLIA assay to aid in the diagnosis of TB infection and can detect both active and latent TB infection. It is designed to work with QIAGEN Quantiferon-TB Gold Plus Blood Collection Tubes which employ TB-specific antigens that elicit both CD8+ and CD4+ T cell responses for accurate assessment of cell-mediated immune response to TB infection.
More details

CLIA Analyzer
LIAISON XS

The LIAISON XS is a fully-automated CLIA analyzer with an efficient design and reduced dimensions that helps achieve higher efficiency and effectively perform low volume specialties and routine tests. It offers a new level of reliability and higher performance in results quality and workflow efficiency and optimization.
More details

ELISA Reader
ELx800

The ELx800 ELISA reader has a compact footprint and proven robust design that makes it an ideal solution for several microplate-based biological assays. Available in 6-, 12-, 24-, 48-, 96- and 384-well capability to meet a variety of assay needs, it is designed for applications within the clinical, biotechnology research and pharmaceutical laboratory.
More details

CLIA Analyzer
LIAISON

The LIAISON CLIA analyzer combines a flexible operating module with a broad menu of assays, resulting in high efficiency due to its lengthy walk-away time. It offers the possibility to run up to 15 different assays at a time, providing rational everyday testing even with a small number of samples.
More details

Zika Virus IgM Assay
LIAISON XL Zika Capture IgM

The LIAISON XL Zika Capture IgM is a first-of-its-kind assay for Zika virus IgM detection that yields results in as little as 51 minutes. The capture assay and the use of recombinant specific antigen assure superior specificity without cross reactions with other Arboviruses.
More details

ELISA Analyzer
Freedom EVOlyzer

The Freedom EVOlyzer is a dedicated platform for the automation of microplate¬based chromogenic ELISAs, and can be easily adapted to meet the changing workflow and throughput requirements of today’s diagnostic laboratory. Controlled by the easy-to-use Freedom EVOlution software, the platform offers outstanding flexibility for a wide variety of ELISA protocols and is designed to reduce hands-on time for ELISA processing.
More details

Chemiluminescence Analyzer
LIAISON XL

The LIAISON XL is a fully automated chemiluminescence analyzer, performing complete sample processing (sample pre-dilutions, sample and reagent dispensing, incubations, wash processes, etc.) as well as measurement and evaluation. It adopts the “Flash” chemiluminescence technology (CLIA) with paramagnetic microparticle solid phase and optimizes throughput by splitting the pipetting phases of reagents and samples into different cycles.
More details

Microtiter Plate Analyzer
ETI-Max 3000

The ETI-Max 3000 is a fully automated microtiter plate analyzer that performs the complete sample processing (sample pre-dilutions, sample and reagent dispensing, incubations, wash processes, plate transports) as well as photometric measurement and evaluation. The instrument is controlled by Windows PC software which allows the user to process pre-defined assays as well as assays programmed by the user.
More details
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions